Avneet K Heer
Datos Biográficos
| ID | 8450567 |
|---|---|
| NOMBRE | Avneet K Heer |
| NOMBRES | Avneet K |
| APELLIDO | Heer |
| FIRMA | HEER A K |
| AFILIACIONES | Haystack Oncology, Baltimore, Maryland |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Use of tumor-informed ctDNA testing to guide adjuvant chemotherapy in postsurgery patients with stage II colon cancer was projected to result in cost savings for both commercial and Medicare Advantage payers. Adoption of ctDNA testing is therefore advantageous from a budgetary perspective
Sin obras prominentes en esta página.
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Use of tumor-informed ctDNA testing to guide adjuvant chemotherapy in postsurgery patients with stage II colon cancer was projected to result in cost savings for both commercial and Medicare Advantage payers. Adoption of ctDNA testing is therefore advantageous from a budgetary perspective
Cancer (1 obras) · Cancer Genomics and Diagnostics (1 obras) · Colorectal cancer (1 obras) · Emergency Medicine (1 obras) · Environmental health (1 obras) · Genetic factors in colorectal cancer (1 obras) · Health care (1 obras) · Health plan (1 obras) · Internal Medicine (1 obras) · Medicare Advantage (1 obras)